Maria Sharapova is investing in a U.S. company, Therabody, formerly called Theragun, which is known for its Theragun percussive massage therapy devices. The former Russian tennis star is also going to be a member of the advisory board of the Los Angeles-based company. Nothing has been reported about the amount of the investment. After Sharapova retired from professional tennis in February 2020 as a five-time Grand Slam title holder, she started to invest in health and wellness companies including Bala Bangles, a producer of wearable wrist and akle weights. Her net worth has been estimated at $192 million and her biggest investment is said to have been her own brand of candies, Sugarpova. Sharapova’s role at Therabody includes working with the brand on its product offerings, advising on initiatives from concept to execution, and supporting the company’s expansion in the European and Asian markets. As a member of Therabody’s advisory board, Sharapova will also advise on corporate partnerships, growth strategies and the future direction of the brand in the tech wellness space, the company said.